SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-002579
Filing Date
2015-05-06
Accepted
2015-05-06 16:20:59
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050615.htm 10-Q 1013219
2 EXHIBIT 31.1 exh_311.htm EX-31.1 14685
3 EXHIBIT 31.2 exh_312.htm EX-31.2 13975
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5688
5 EXHIBIT 32.2 exh_322.htm EX-32.2 5541
  Complete submission text file 0001171843-15-002579.txt   8082555

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20150331.xml EX-101.INS 1482508
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20150331.xsd EX-101.SCH 58049
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20150331_cal.xml EX-101.CAL 51024
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20150331_def.xml EX-101.DEF 277651
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20150331_lab.xml EX-101.LAB 347924
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20150331_pre.xml EX-101.PRE 275223
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 15837285
SIC: 2834 Pharmaceutical Preparations